Actively Recruiting
Initial Predictors of Long-term Brain Resilience After Minor Ischemic Stroke: a Study Nested in the Brest Stroke Population-based Registry
Led by University Hospital, Brest · Updated on 2026-02-23
1000
Participants Needed
1
Research Sites
52 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This research aims to develop a predictive model for quality of life more than four years after a minor ischemic stroke. It focuses on patients with mild stroke deficits, defined by a National Institute of Health Stroke Scale (NIHSS) score of 5 or less, to better understand long-term outcomes. The study will analyze both retrospective and prospective data from the Brest Stroke Registry, including patient characteristics collected shortly after stroke onset. Participants include patients who suffered a minor ischemic stroke over four years ago and are part of the Brest Stroke Registry. They may take part through telephone or face-to-face interviews with neurologists and clinical research technicians. Optional procedures include providing a saliva sample for DNA analysis and undergoing a cerebral MRI without contrast. The study will use questionnaires to assess quality of life and cognitive function, with data linked from hospital records and the registry. During the study, participants will complete quality of life and cognitive questionnaires and may provide saliva samples and have an MRI scan. Researchers will measure various outcomes such as quality of life scores, cognitive assessments, disability scales, depression and anxiety screening, and stroke recurrence. The study includes over four years of follow-up, with data collected at inclusion and the possibility of long-term monitoring of brain resilience after minor ischemic stroke.
CONDITIONS
Brief Title
BREMISS : Brain Resilience Minor Stroke Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Cases of stroke in the Brest Stroke Registry
- Ability to sign informed consent
- Patients followed-up more than 4 years during the study period
- NIHSS score 5 or less on admission
- First stroke between 18 and 75 years old
- Rankin score before stroke less than 1
- Possibility to provide saliva samples for genomic study
- Possibility to perform cerebral MRI
You will not qualify if you...
- Patients with transient neurological deficits resolving within one hour and normal brain imaging
- Not affiliated to social security
- Patient under legal protection or deprived of liberty by judicial or administrative decision
- Patient unable to sign informed consent
- Patient whose follow-up will be impossible
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or by telephone)
Duration - 1 day
Participants undergo cerebral MRI and provide saliva samples for DNA analysis either during a face-to-face visit or by sending samples from home. Additionally, quality of life and cognitive questionnaires are completed.
1 visit (in-person) or home sample collection
Duration - More than 4 years
Participants’ long-term brain resilience and quality of life are observed more than 4 years after minor ischemic stroke, based on retrospective and prospective data collection.
1 telephone or face-to-face follow-up interview
Trial Site Locations
Total: 1 location
1
CHU de Brest
Brest, France, 29609
Actively Recruiting
Research Team
S
Serge TIMSIT, Pr
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here